BIG
HRMY icon

Brooklyn Investment Group’s Harmony Biosciences HRMY Stock Holding History

Brooklyn Investment Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,288
Closed -$40.7K – 1574
2025
Q2 		$40.7K Buy
1,288
+224
+21% +$7.21K 0.01% 1453
2025
Q1 		$35.3K Buy
1,064
+970
+1,032% +$34.8K 0.01% 929
2024
Q4 		$3.23K Buy
+94
New +$3.23K ﹤0.01% 1343

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brooklyn Investment Group's HRMY Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 1,288 shares — an estimated $40.7K sold.

Brooklyn Investment Group first reported a position in HRMY in Q4 2024 and held it in 3 quarters. The position peaked at $40.7K in Q2 2025. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 1,288 Harmony Biosciences shares in Q3 2025, an estimated $40.7K.
  • Brooklyn Investment Group first reported a position in Harmony Biosciences in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Harmony Biosciences position peaked at $40.7K in Q2 2025.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.